title: Dihydroergotamine suppositories in a headache clinic.
abstract: Dihydroergotamine (DHE) is available in the United States for parenteral use. We report a preliminary trial of DHE suppositories in an outpatient headache clinic setting. Dihydroergotamine suppositories may be appropriate for patients with catamenial migraine and classic migraine in particular.
authors.affiliation: Dartmouth Medical School, Hanover, New Hampshire.
authors.forename: T N
authors.initials: TN
authors.lastname: Ward
authors.forename: G
authors.initials: G
authors.lastname: Scott
mesh_terms: D004087:Dihydroergotamine / Q000008:administration & dosage* / Q000009:adverse effects; D006261:Headache / Q000188:drug therapy*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D013488:Suppositories
chemical_list: D013488:Suppositories; D004087:Dihydroergotamine